Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents

Some patients with hepatitis C virus (HCV) infections who fail to achieve sustained virological responses (SVRs) after interferon (IFN) therapy do not develop hepatocellular carcinoma (HCC). Risk stratification of these patients may help identify those who would benefit most from treatment with dire...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chao-Min, Hu, Tsung-Hui, Chang, Kuo-Chin, Tseng, Po-Lin, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng, Lee, Chuan-Mo, Tsai, Ming-Chao, Lin, Ming-Tsung, Yen, Yi-Hao, Hung, Chao-Hung, Cho, Chung-Lung, Wu, Cheng-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704851/
https://www.ncbi.nlm.nih.gov/pubmed/29145306
http://dx.doi.org/10.1097/MD.0000000000008696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704851/
https://www.ncbi.nlm.nih.gov/pubmed/29145306
http://dx.doi.org/10.1097/MD.0000000000008696

Ejemplares similares